Mick Hellman increased its stake in Nice Ltd (NICE) by 18.86% based on its latest 2017Q3 regulatory filing with the SEC. Hmi Capital Llc bought 158,000 shares as the company’s stock rose 7.66% with the market. The hedge fund run by Mick Hellman held 995,562 shares of the computer manufacturing company at the end of 2017Q3, valued at $80.95M, up from 837,562 at the end of the previous reported quarter. Hmi Capital Llc who had been investing in Nice Ltd for a number of months, seems to be bullish on the $5.21B market cap company. The stock decreased 0.49% or $0.45 during the last trading session, reaching $90.93. About 90,361 shares traded. NICE Ltd. (NASDAQ:NICE) has risen 16.65% since January 31, 2017 and is uptrending. It has underperformed by 0.05% the S&P500.
James E. Flynn increased its stake in Epizyme Inc (EPZM) by 5.76% based on its latest 2017Q3 regulatory filing with the SEC. Deerfield Management Company bought 38,157 shares as the company’s stock rose 39.84% with the market. The hedge fund run by James E. Flynn held 700,526 shares of the health care company at the end of 2017Q3, valued at $13.35M, up from 662,369 at the end of the previous reported quarter. Deerfield Management Company who had been investing in Epizyme Inc for a number of months, seems to be bullish on the $1.20 billion market cap company. The stock increased 2.07% or $0.35 during the last trading session, reaching $17.25. About 424,936 shares traded. Epizyme, Inc. (NASDAQ:EPZM) has risen 91.85% since January 31, 2017 and is uptrending. It has outperformed by 75.15% the S&P500.
Investors sentiment decreased to 1.46 in Q3 2017. Its down 0.47, from 1.93 in 2017Q2. It dropped, as 15 investors sold EPZM shares while 22 reduced holdings. 13 funds opened positions while 41 raised stakes. 58.04 million shares or 22.28% more from 47.46 million shares in 2017Q2 were reported. New York-based Morgan Stanley has invested 0% in Epizyme, Inc. (NASDAQ:EPZM). Secor Cap Advsrs Lp stated it has 0.13% in Epizyme, Inc. (NASDAQ:EPZM). Manufacturers Life Ins The has 0% invested in Epizyme, Inc. (NASDAQ:EPZM) for 32,446 shares. Pacad Inv Ltd reported 4,000 shares. Qs Ltd holds 92,668 shares. Barclays Public Limited holds 0% or 27,920 shares. Wells Fargo & Mn has invested 0% in Epizyme, Inc. (NASDAQ:EPZM). Aqr Cap Mngmt Lc holds 0% of its portfolio in Epizyme, Inc. (NASDAQ:EPZM) for 32,692 shares. Baker Bros Advsr Lp has 0.04% invested in Epizyme, Inc. (NASDAQ:EPZM). California Pub Employees Retirement Systems owns 135,500 shares. Invesco accumulated 0% or 405,513 shares. Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Epizyme, Inc. (NASDAQ:EPZM). Proshare Advisors Ltd Company holds 0.01% or 35,767 shares in its portfolio. 31,766 were accumulated by Woodstock. 5,336 were accumulated by Royal Bancshares Of Canada.
Since August 24, 2017, it had 1 buy, and 3 insider sales for $2.32 million activity. MOTT DAVID M bought 200,000 shares worth $3.05 million.
Among 12 analysts covering Epizyme (NASDAQ:EPZM), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Epizyme had 30 analyst reports since August 6, 2015 according to SRatingsIntel. H.C. Wainwright maintained Epizyme, Inc. (NASDAQ:EPZM) on Thursday, June 15 with “Buy” rating. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, June 7 report. Jefferies initiated the shares of EPZM in report on Wednesday, January 24 with “Buy” rating. Mizuho maintained the shares of EPZM in report on Tuesday, May 10 with “Buy” rating. The company was maintained on Monday, June 12 by RBC Capital Markets. The rating was maintained by Oppenheimer on Monday, June 5 with “Buy”. Oppenheimer maintained the shares of EPZM in report on Tuesday, August 1 with “Buy” rating. The stock has “Buy” rating by Mizuho on Thursday, August 6. The stock of Epizyme, Inc. (NASDAQ:EPZM) has “Buy” rating given on Tuesday, August 25 by Zacks. On Friday, October 27 the stock rating was maintained by SunTrust with “Buy”.
Deerfield Management Company, which manages about $4.41 billion and $2.22 billion US Long portfolio, decreased its stake in Wave Life Sciences Ltd by 166,841 shares to 580,000 shares, valued at $12.62M in 2017Q3, according to the filing. It also reduced its holding in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 328,461 shares in the quarter, leaving it with 632,686 shares, and cut its stake in Audentes Therapeutics Inc.
The post As Nice LTD (NICE) Share Value Rose, Hmi Capital Boosted Its Position; Epizyme (EPZM) Share Value Rose While Deerfield Management Company Raised Stake by $724,983 appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/01/31/as-nice-ltd-nice-share-value-rose-hmi-capital-boosted-its-position-epizyme-epzm-share-value-rose-while-deerfield-management-company-raised-stake-by-724983/
No comments:
Post a Comment